BOOSTCAMP: Boosting the endocannabinoid system before the treatment of anxiety symptoms
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with anxiety. Other eligibility criteria apply.
- Listed locations
- UtrechtSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University Medical Center Utrecht
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Netherlands
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2020-003739-62
- Official title
Show the full official title
BOOSTCAMP: Boosting the endocannabinoid system before the treatment of anxiety symptoms
Recruitment & locations
Utrecht
Registry details
Original registry record (opens in a new tab)- Netherlands — Ongoing, recruitment ended
- Netherlands — Trial now transitioned
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Medical Center Utrecht, a hospital or academic medical center.
Who can participate?
This study is for people with anxiety. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
